When fear drives markets, it often prices good companies as though their futures have already failed. Two Canadian technology firms — Lightspeed Commerce and WELL Health Technologies — have been swept down by sector-wide skepticism, yet analysts and early signs of recovery suggest the market's verdict may be premature. In the long arc of investing, the distance between a stock's current price and its underlying potential is sometimes less a warning than an invitation. The patient question is not whether these companies have a future, but whether the market will recognize it before others do.
Two Tech Stocks Analysts See Doubling as Market Pressure Creates Value Opportunities
Cheap doesn't mean safe—it just means the market has already priced in bad news.
Mark
Why should anyone trust analyst price targets? They've been wrong before.
Mimi
Fair point. But these targets aren't wild speculation—they're based on the companies' actual assets, revenue growth, and market opportunity. The real question is timing. An analyst can be right about where a stock should trade and still be early.
Mark
So what changed with Lightspeed? Why was the short-seller report so damaging?
Mimi
The report raised legitimate questions about whether two billion in acquisitions in two years made sense. But the recent earnings showed those deals are actually generating returns. That's the kind of thing that takes time to prove.
Mark
And WELL Health—is telemedicine really a permanent shift, or will it fade once the pandemic ends?
Mimi
The convenience is real. Patients save time, providers save overhead. Even if COVID disappears, those economics don't change. The question is whether WELL Health can execute well enough to capture that value.
Mark
Both stocks are up 21 percent in the last month. Isn't that a sign the bargain is already gone?
Mimi
It could be. Or it could be the beginning of a longer recovery. A month of gains doesn't erase a year of losses. The real test is whether the fundamentals—profitability at Lightspeed, revenue growth at WELL—actually materialize.
Mark
What's the real risk here?
Mimi
Execution. Both companies have to deliver on their growth plans. And the broader tech sector could stay under pressure for longer than anyone expects. Cheap doesn't mean safe—it just means the market has already priced in a lot of bad news.
Il Polso
- Lightspeed Commerce absorbed a devastating 57% collapse over the past year, triggered by a short-seller attack and a CEO departure that shook investor confidence to its core.
- WELL Health Technologies fell nearly 48% from its year-ago price, despite operating in telemedicine — a sector the pandemic proved essential and convenience will keep relevant.
- Both stocks have quietly surged 21% in the past month alone, hinting that early believers are beginning to act on what the broader market has not yet accepted.
- Analysts project Lightspeed could reach $80 per share and WELL Health could nearly triple to $11.17 — gaps so wide they define what value investors call a margin of safety.
- The real tension is not about whether these companies can grow, but whether they can execute fast enough before market patience runs out and the narrative hardens against them.
When fear drives markets, it often prices good companies as though their futures have already failed. Two Canadian technology firms — Lightspeed Commerce and WELL Health Technologies — have been swept down by sector-wide skepticism, yet analysts and early signs of recovery suggest the market's verdict may be premature. In the long arc of investing, the distance between a stock's current price and its underlying potential is sometimes less a warning than an invitation. The patient question is not whether these companies have a future, but whether the market will recognize it before others do.
When the technology sector sells off broadly, it rarely discriminates between the genuinely broken and the temporarily bruised. Two Canadian companies — Lightspeed Commerce and WELL Health Technologies — appear to belong to the second category, even as their share prices tell a harsher story.
Lightspeed Commerce spent over two billion dollars on acquisitions in just two years, a pace that alarmed investors already rattled by a short-seller report in September 2021 that sent shares down 30 percent in a single blow. A leadership transition followed, with founder Dax Dasilva stepping aside for JP Chauvet — a move the market read as distress. Yet the most recent earnings report offered a different reading: the acquisitions are beginning to integrate, profitability is within reach, and analysts still see the stock reaching $80 per share. After falling 57 percent over the past year, Lightspeed has gained 21 percent in just the last month — a quiet signal that the turnaround story is finding believers.
WELL Health Technologies operates in a sector that earned its relevance during the pandemic and shows no sign of retreating. The company has steadily built a network of clinics and digital health platforms across Canada and the United States, with a recent U.S. acquisition already contributing real revenue. Yet the stock sits at just $4.50 per share — down 48 percent from a year ago — trading at only 1.64 times book value. Analysts place its fair value near $11.17, nearly triple the current price. Like Lightspeed, it too has climbed 21 percent in the past month.
Both companies share a common condition: real growth ahead, prices shaped by fear rather than fundamentals, and a gap between market perception and analyst conviction that defines genuine value territory. The bet an investor makes here is not simply on a company's potential — it is on whether the market will revise its incomplete story before the opportunity closes.
When the tech sector stumbles, the real bargains emerge—if you know where to look. Two Canadian companies have been hammered by market skepticism and sector-wide pressure, but analysts see them as potential doubles for patient investors willing to buy when others are selling.
Lightspeed Commerce has spent the past year absorbing a body blow. In September 2021, a short-seller report from Spruce Point Capital Management sent shares plummeting 30 percent. The company had spent over two billion dollars acquiring other businesses in just two years, a spending spree that left investors questioning whether management had lost its way. Then came the leadership change: founder and former CEO Dax Dasilva stepped aside, replaced by JP Chauvet. The market read it as a sign of trouble.
Yet something shifted in the most recent earnings report. The acquisitions, it turned out, were beginning to work. Chauvet signaled the company was on track toward profitability. Analysts, despite trimming their price targets in response to broader tech sector weakness, still see substantial upside. Their consensus target sits at eighty dollars per share—a meaningful jump from where the stock trades today. Over the past year, Lightspeed shares have fallen 57 percent. But in just the last month, they've climbed 21 percent, suggesting the market may be starting to believe the turnaround story.
The second candidate is WELL Health Technologies, a company positioned in a sector that has only grown more relevant. Telemedicine proved its worth during the pandemic, and the convenience it offers—to patients and healthcare providers alike—is unlikely to disappear. WELL Health has been methodical in building its footprint, acquiring clinics and platforms across Canada and the United States. A recent acquisition in the U.S. is already generating meaningful revenue.
Yet the stock trades at just four dollars and fifty cents per share, a 48 percent decline from a year ago. The company now trades at 1.64 times book value, a metric that suggests genuine cheapness. Analysts have assigned it a consensus target price of eleven dollars and seventeen cents—nearly triple the current level. That kind of gap between where a stock trades and where analysts believe it should trade is the definition of value territory. Like Lightspeed, WELL Health has also gained 21 percent over the past month, a sign that some investors are beginning to see what the analysts see.
Both stocks carry the same fundamental story: they operate in sectors with real growth ahead, they've been beaten down by broader market skepticism about technology stocks, and they're now priced in a way that offers genuine margin of safety. The question for any investor isn't whether these companies will eventually succeed—the question is whether they'll succeed fast enough, and whether the market will give them time to prove it. That's always the bet you're making when you buy a beaten-down stock: that the story the market has written about the company is incomplete.
Citazioni salienti
New CEO JP Chauvet signaled the company was on track toward profitability— Lightspeed Commerce leadership
Telemedicine offers patients and healthcare providers too many time and cost savings to be ignored— Market analysis on WELL Health sector
Vuoi la storia completa?
Leggi l'originale su The Motley Fool Canada ↗
Economy & Finance